A pharmacy receives the following prescription Ipratropium bromide/albuterol sulfate inhalation solution 0.5 mg/3 mg 3 mL nebulizer vials in a carton of 30 Inh 1 vial q.i.d. x 10 days #30. The prescriber should be contacted because:

The package size of 30 vials is not inherently incorrect, as it is a standard carton size for inhalation solutions. The issue here is not about the package size itself but rather the quantity needed based on the prescribed usage.

The prescribed dosage of 0.5 mg of ipratropium bromide and 3 mg of albuterol sulfate per nebulizer vial is within the accepted therapeutic range for these medications. There is no indication that the dosage itself presents a problem; thus, this choice does not warrant contacting the prescriber.

Ipratropium bromide and albuterol sulfate are available in various forms, including nebulizer solutions and metered-dose inhalers. Therefore, stating that the medication is only available as a metered-dose inhaler is inaccurate and does not necessitate contacting the prescriber.